Companies:
50,165
Total Market Cap:
139204617891906.08
Global Rank
#24539
Country Rank
#1060
Market Cap
103.98 M
Price
4.42
Change (%)
1.92%
Volume
25,934
CTCBIO's latest marketcap:
103.98 M
As of 08/02/2025, CTCBIO's market capitalization has reached $103.98 M. According to our data, CTCBIO is the 24539th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 103.98 M |
| Revenue (ttm) | 104.63 M |
| Net Income (ttm) | -3,097,158.4 |
| Shares Out | 23.91 M |
| EPS (ttm) | -0.13 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2009 |
| Earnings Date | 08/21/2025 |
Market Cap Chart
Data Updated: 08/02/2025
CTCBIO's yearly market capitalization.
CTCBIO has seen its market value drop from ₩293.4 B to ₩144.41 B since 2014, representing a total decrease of 50.78% and an annual compound decline rate (CAGR) of 6.47%.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₩144.41 B | $103.98 M | -3.82% | 24539 |
| 12/30/2024 | ₩156.6 B | $104.92 M | -38.79% | 22942 |
| 12/28/2023 | ₩255.82 B | $196.98 M | 69.84% | 18918 |
| 12/29/2022 | ₩150.63 B | $118.99 M | -28.8% | 21150 |
| 12/30/2021 | ₩211.56 B | $177.71 M | 32.09% | 19517 |
| 12/30/2020 | ₩160.17 B | $147.35 M | 37.91% | 18397 |
| 12/30/2019 | ₩116.13 B | $99.87 M | -24.69% | 18139 |
| 12/28/2018 | ₩154.21 B | $137.25 M | -30.91% | 15687 |
| 12/28/2017 | ₩223.21 B | $207.58 M | 23.57% | 14452 |
| 12/29/2016 | ₩180.63 B | $148.12 M | -31.62% | 14113 |
Company Profile
About CTCBIO Inc.
CTCBIO Inc. is a pharmaceutical company based in Hwaseong-si, South Korea, with a global presence. Since its founding in 1993, the company has specialized in developing and distributing a wide range of pharmaceutical and health-related products.
Product Offerings
- Pharmaceuticals: Animal and human medications across multiple therapeutic areas.
- Feed Additives & Ingredients: Nutritional and functional additives for animal feed.
- Functional Foods: Health-enhancing food products.
Therapeutic Categories
- Cardiovascular, gastrointestinal, and osteoporosis treatments
- Antibiotics, antifungals, and antivirals
- Antiepileptic and neuropsychiatric medications
- Allergy, dermatology, and genito-urinary solutions
- Diabetes, anti-inflammatory, and hormone therapies
- COVID-19 Testing: CTC COVID-19 IgM/IgG combo test kit
Additional Products
- Pharmaceutical excipients (coating agents, disintegrants, lubricants, etc.)
- Biopharma and solubilizer solutions
- APIs (Active Pharmaceutical Ingredients)
- Animal drugs, physiological activators, and disinfectants
CTCBIO Inc. continues to innovate in pharmaceuticals and health products, serving both domestic and international markets.
Frequently Asked Questions
-
What is CTCBIO's (KOSDAQ-060590) current market cap?As of 08/02/2025, CTCBIO (including the parent company, if applicable) has an estimated market capitalization of $103.98 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CTCBIO (KOSDAQ-060590) rank globally by market cap?CTCBIO global market capitalization ranking is approximately 24539 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.